The North America Kidney Function Tests Market would witness market growth of 6.9% CAGR during the forecast period (2021-2027). Clearance tests are considered as the gold standard for observation and assessment of glomerular filtration rate.
Inulin and creatinine tests are included in these products, which offer an essential addition to conventional diagnostic tests in order to generate accurate results. In addition to it, these make sure that there is the lowest variation in performance due to their optimum sensitivity and accuracy. The adoption of kidney function tests is set to increase due to the low cost and high availability of these products.
Due to the increasing prevalence of Chronic kidney disease around the world and the huge economic cost related to it, the disease has become a global public health concern. As per the National Institutes of Health (NIH), the worldwide occurrence of CKD is approximately 14%. Besides, the rates of CKD risk factors like hypertension, diabetes, and obesity are constantly increasing due to the changing lifestyle patterns. This has resulted in a massive demand for essential screening tests in patients with hypertension and diabetes for CKD, hence boosting the adoption rate of the product. According to the study conducted by the International Diabetes Federation, in 2019, approximately 463 million individuals had diabetes around the globe, which would arrive at 700 million by 2045.
The US market dominated the North America Blood Tests Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $80 million by 2027. The Canada market is experiencing a CAGR of 8.3% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 7.3% during (2021 - 2027).
Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Kidney Function Tests Market is Estimated to Reach USD 1.4 Billion by 2027 at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
By Product
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
